BRIEF published on 10/21/2024 at 14:30, 1 month 1 day ago Britvic Directors Increase Shareholdings Under Incentive Plan Stock Exchange Shareholding Directors Incentive Plan Britvic
PRESS RELEASE published on 10/21/2024 at 14:25, 1 month 1 day ago Director/PDMR Shareholding Britvic plc Directors purchase shares and receive matching shares under Share Incentive Plan. Details of transactions and interests disclosed Transactions Share Incentive Plan Britvic Plc Directors Matching Shares
BRIEF published on 10/16/2024 at 15:32, 1 month 6 days ago Vanguard Group Discloses Position in Britvic plc Securities Disclosure Britvic Plc Takeover Code Vanguard Group
PRESS RELEASE published on 10/16/2024 at 15:27, 1 month 6 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses a 5.47% stake in Britvic plc through Form 8.3 as of 15 October 2024 Form 8.3 Britvic Plc Vanguard Group Stake Disclosure Financial Holdings
BRIEF published on 10/15/2024 at 14:51, 1 month 7 days ago Vanguard Group Discloses Britvic Stake Under Takeover Code Position Disclosure Securities Dealings Takeover Code Vanguard Group Britvic Stake
PRESS RELEASE published on 10/15/2024 at 14:46, 1 month 7 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses 5.46% stake in Britvic plc as of 14 Oct '24. Detailed Form 8.3 submission according to Takeover Code Form 8.3 Disclosure Britvic Plc Takeover Code Vanguard Group
BRIEF published on 10/14/2024 at 15:15, 1 month 8 days ago The Vanguard Group Reports Position in Britvic plc Britvic Plc Takeover Code Stock Purchase Vanguard Group Share Disclosure
PRESS RELEASE published on 10/14/2024 at 15:10, 1 month 8 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses holding 5.46% stake in Britvic plc. Purchase of 20p ordinary shares reported at 12.81 GBP and 12.83 GBP per unit Britvic Plc The Vanguard Group Purchase Stake Disclosure 20p Ordinary Shares
BRIEF published on 10/11/2024 at 15:36, 1 month 11 days ago Britvic Plc Discloses Major Shareholding Change Voting Rights Britvic Plc Financial Disclosure Shareholding UK Company
PRESS RELEASE published on 10/11/2024 at 15:31, 1 month 11 days ago Holding(s) in Company Britvic plc (BVIC) notified a major holding in the company on 10-Oct-2024. The total voting rights held in the issuer is 5.581100% Voting Rights Britvic Plc BVIC Notification Major Holding
Published on 11/22/2024 at 18:45, 3 hours 27 minutes ago CORRECTING and REPLACING the Not-So-Secret Lives of REAL "Mormon" Wives - the Eye-Opening New Book From Cedar Fort Publishing & Media - is Now Available for Purchase, Just in Time for Christmas
Published on 11/22/2024 at 16:00, 6 hours 12 minutes ago Manimal Tales Unveils Two New Personalized Christmas-Themed Books to Spread Holiday Magic and Joy!
Published on 11/22/2024 at 15:55, 6 hours 17 minutes ago Independent Proxy Advisory Firm ISS Recommends Signal Gold Shareholders Vote for Arrangement Resolution and Private Placement Resolution
Published on 11/22/2024 at 15:15, 6 hours 57 minutes ago Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Published on 11/22/2024 at 14:45, 7 hours 27 minutes ago Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Published on 11/22/2024 at 18:14, 3 hours 58 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 4 hours 19 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 5 hours 17 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 6 hours 12 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 1 day 15 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 2 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 4 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 4 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
